Lincoln Pharmaceuticals Ltd
NSE:LINCOLN
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LINCOLN's stock price target?
Not Available
LINCOLN doesn't have any price targets made by Wall Street professionals.
What is Lincoln Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
20%
For the last 13 years the
compound annual growth rate for
Lincoln Pharmaceuticals Ltd's revenue is
10%.
The projected
CAGR
for the next 2 years is
20%.
What is Lincoln Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
31%
For the last 13 years the
compound annual growth rate for
Lincoln Pharmaceuticals Ltd's operating income is
17%.
The projected
CAGR
for the next 2 years is
31%.
What is Lincoln Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
34%
For the last 13 years the
compound annual growth rate for
Lincoln Pharmaceuticals Ltd's net income is
24%.
The projected
CAGR
for the next 2 years is
34%.
